Advantage of Pelletised API in Modern Ibuprofen Formulation
Advantage of Pelletised API defines a new standard in ibuprofen product development. Manufacturers constantly seek robust, scalable, and cost-efficient formulation strategies. However, conventional ibuprofen powder creates technical obstacles that slow down progress.
Why Conventional Ibuprofen Powder Limits Formulation Performance
Ibuprofen is one of the most widely used non-steroidal anti-inflammatory drugs (NSAIDs). Companies formulate it for pain relief, fever reduction, and inflammation control. Nevertheless, its raw material properties complicate processing.
Conventional ibuprofen powder shows poor flowability. In addition, irregular particle size distribution increases segregation risk during blending. As a result, manufacturers often struggle with content uniformity.
Moreover, ibuprofen has an inherently bitter taste. Therefore, formulators must apply effective taste-masking strategies. Traditional methods rely on heavy coatings, sweeteners, or multi-step granulation. Consequently, production time and costs increase.
These challenges become critical in orally disintegrating tablets, stick packs, and sachets. In such formats, precise blending and reliable coating are essential. However, powder variability often undermines consistency.
Advantage of Pelletised API for Improved Processability
The Advantage of Pelletised API begins with particle engineering. IPC Process-Center GmbH (Germany) is the manufacturer behind Ibuprofen DC100 and produces granules consisting entirely of ibuprofen. Because of their defined size and morphology, these granules flow more consistently through equipment.
As a result, blending becomes more predictable. Furthermore, uniform particle geometry minimizes segregation during handling. Consequently, manufacturers achieve better content uniformity.
Agglomerated particles also improve coating performance. Smooth and regular surfaces allow even application of taste-masking layers. Thus, formulators reduce coating variability and optimize sensory performance.
In addition, controlled particle size supports reproducible downstream processing. Therefore, production teams gain greater operational stability.
Direct Compression Benefits and Manufacturing Efficiency
Direct compression strongly benefits from pellet technology. Granulated ibuprofen enables stable tableting without prior granulation. Therefore, manufacturers simplify their workflows.
Process with conventional ibuprofen.
Process with Ibuprofen DC100.
At the same time, they maintain high drug loading and mechanical strength. Moreover, improved flow properties support high-speed tableting operations. Consequently, companies increase throughput while reducing process risk.
The Advantage of Pelletised API ultimately combines formulation flexibility with manufacturing efficiency. Instead of compensating for raw material weaknesses, developers design robust oral dosage forms from the start. As a result, they secure both technical reliability and commercial competitiveness in demanding pharmaceutical markets.
Expert’s opinion
From a formulation science perspective, granulated Ibuprofen represents a decisive technical improvement over conventional powder. It enhances flow, supports uniform coating, and simplifies direct compression (DC). As a result, manufacturers gain greater process robustness, scalability, and sensory control. In competitive OTC and prescription markets, this approach delivers clear operational and commercial advantages.
